M L Romick

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.

Megan Sykes, M L Romick, D H Sachs · Proceedings of the National Academy of Sciences · 1990 · 115 citations · Full text

Life Sciences, Hematology, Immunology +14

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Megan Sykes, M L Romick, K A Hoyles et al. · The Journal of Experimental Medicine · 1990 · 95 citations · Full text

Life Sciences, Hematology, Immunology +13

In vitro and in vivo analysis of bone marrow-derived CD3+, CD4−, CD8−, NK1.1+ cell lines

Megan Sykes, K A Hoyles, M L Romick et al. · Cellular Immunology · 1990 · 53 citations

Life Sciences, Cell Biology, Immunology +10

Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients.

Megan Sykes, Caroline H. Chester, Thoralf M. Sundt et al. · The Journal of Immunology · 1989 · 50 citations

Life Sciences, Cell Biology, Immunology +15